A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
11/2004
11/11/2004	WO2004096806A1 Fused imidazole derivative
11/11/2004	WO2004096796A1 Novel aniline derivatives, their manufacture and use as pharmaceutical agents
11/11/2004	WO2004096795A2 C-fms kinase inhibitors
11/11/2004	WO2004096792A2 Novel indole derivatives, method of preparing same in the form of medicaments, pharmaceutical compositions and, in particular, kdr inhibitors
11/11/2004	WO2004096780A1 Quinoxalinone-3- one derivatives as orexin receptor antagonists
11/11/2004	WO2004096742A1 Hydroanthracene based compounds as anticancer agents
11/11/2004	WO2004096293A2 Method and device for radiotherapy
11/11/2004	WO2004096291A1 In vivo imaging using peptide derivatives
11/11/2004	WO2004096289A1 Gene introduction efficiency enhancer
11/11/2004	WO2004096275A1 Instrument for inducing cytokine and method of inducing cytokine
11/11/2004	WO2004096273A1 Methods for treating interleukin-6 related diseases
11/11/2004	WO2004096262A1 Method of preparing a medicament for anti-tumour therapy involving neutrophils (neutrophil therapy)
11/11/2004	WO2004096259A1 Methods and compositions using gonadotropin hormone releasing hormone
11/11/2004	WO2004096249A1 A composition containing radix codonopsis pilosulae and radix astragali and hedysari, method of producing it and use thereof
11/11/2004	WO2004096247A1 Instrument for inducing cytokine and method of inducing cytokine
11/11/2004	WO2004096246A1 Antiallergic composition
11/11/2004	WO2004096239A1 Method for administration of troxacitabine
11/11/2004	WO2004096226A1 Quinazoline derivatives and their use in the treatment of cancer
11/11/2004	WO2004096224A2 Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells, or angiogenesis
11/11/2004	WO2004096223A1 Use of irinotecan for treatment of resistant breast cancer
11/11/2004	WO2004096212A1 Pyrazole compounds as hsp90 inhibitors for the treatment of cancer
11/11/2004	WO2004096206A2 Therapeutic combination of a cox-2 inhibitor and a tace inhibitor
11/11/2004	WO2004096129A2 Inhibitors of akt activity
11/11/2004	WO2004083430A3 SHORT INTERFERING RNA (siRNA) ANALOGUES
11/11/2004	WO2004083231A3 Use of peptide ligands for plasma membrane receptors or similar for mitochondrial activity modulation
11/11/2004	WO2004082579A3 Nemorubicin as radiosensitizer in combination with radiation therapy against tumors
11/11/2004	WO2004080477A8 Aplidine for multiple myeloma treatment
11/11/2004	WO2004078748A3 Novel bicyclic urea derivatives useful in the treatment of cancer and other disorders
11/11/2004	WO2004078133A3 Antineoplastic combinations comprising a rapamycin derivative and an aromatase inhibitor
11/11/2004	WO2004078110A3 Fused imizadoles as transforming growth factor (tgf) inhibitors
11/11/2004	WO2004074244A3 Pyrimidine compounds
11/11/2004	WO2004069274A3 Sensitizing cells for apoptosis by selectively blocking cytokines
11/11/2004	WO2004065422A3 Cancerous disease modifying antibodies
11/11/2004	WO2004038407A3 Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 12 (gpr12)
11/11/2004	WO2004035021A3 Buccal polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
11/11/2004	WO2004026844A9 Methods and compositions of novel triazine compounds
11/11/2004	WO2004012681A3 Cancer vaccines containing epitopes of oncofetal antigen
11/11/2004	WO2004011625A3 Polymorphisms for predicting disease and treatment outcome
11/11/2004	WO2003097356A9 Camptothecin derivatives and polymeric conjugates thereof
11/11/2004	WO2003087411A8 Method to inhibit cell growth using oligonucleotides
11/11/2004	WO2003079973A3 Mitotic kinesin inhibitors
11/11/2004	WO2003038052A3 Nucleic acid-associated proteins
11/11/2004	US20040225123 Substituted phenyl naphthalenes as estrogenic agents
11/11/2004	US20040225118 31 human secreted proteins
11/11/2004	US20040225114 IGF-1 receptor interacting proteins
11/11/2004	US20040225111 Therapy for osteoporosis
11/11/2004	US20040225016 administering bis[thio-hydrazide amide] Compounds for treating multi-drug resistant cancer
11/11/2004	US20040225013 Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents
11/11/2004	US20040225011 E.g., ajulemic acid; used for decreasing cell proliferation
11/11/2004	US20040225003 4,6-Dimethyl-3-{[3'-(N,N-dimethylaminomethyl)-4-hydroxy-4'-(3''-methoxyphenyl)-cyclohexylamino]-methyl}-1H-indole 2-carboxylic acid ethyl ester or other derivatives of substituted indoles; for treatment or prevention of neurodegenerative diseases, psychological disorders, AIDS, inflammation or allergies
11/11/2004	US20040225002 Derivatives of isoindigo, indigo and indirubin and methods of treating cancer
11/11/2004	US20040224991 Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activity
11/11/2004	US20040224988 Administering 6-[2-(methylcarbamoyl)phenylsulfanyl]-3-E-[2-(pyridin-2-yl)ethenyl]indazole as dosage form to treat cancer
11/11/2004	US20040224986 Piperidinyl targeting compounds that selectively bind integrins
11/11/2004	US20040224985 for controlling weight; pyrrolidine or piperidine compounds
11/11/2004	US20040224977 Racemic mixtures for treatment of diseases with alpha 7nicotinic acetyl chloline administering
11/11/2004	US20040224972 Medicinal compositions for concomitant use as anticancer agent
11/11/2004	US20040224971 Substituted azaindole as drugs and enzyme inhibitors
11/11/2004	US20040224970 Preparation and use of 1,5,6,7-tetrahydropyrrolo[3,2-c]pyridine derivatives for treatment of obesity
11/11/2004	US20040224968 Drugs for treatment of tumors, antidiabetic agents, antiproliferation agents and injections
11/11/2004	US20040224966 Enzyme inhibitors as drugs for cardiovascular disorders, aids, alzheimers disease or urogenital disorders
11/11/2004	US20040224965 Treatment of cardiovascular disorders, thrombosis, surgery and nhe inhibitors
11/11/2004	US20040224930 25-SO2-Substituted analogs of 1mu,25-dihydroxyvitamin D3
11/11/2004	US20040224929 Novel vitamin D analogs
11/11/2004	US20040224925 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs
11/11/2004	US20040224924 Programming a specific course and rate for a parent drug compound's metabolism that leads to an inactive or weakly active and non-toxic metabolite when the parent drug compound is administered, comprising modifying the parent drug compound by forming one or more of a predetermined chemical arrangement
11/11/2004	US20040224919 Restoring cancer-suppressing functions to neoplastic cells through DNA hypomethylation
11/11/2004	US20040224911 Transporters and ion channels
11/11/2004	US20040224909 For inhibiting proliferation of a human tumor cell
11/11/2004	US20040224904 Carbohydrate scaffold, carrying two side chains, which form a macrocyclic ring that may be unsaturated and contains ether, amide, ester and/or carbamate groups; for therapy of bacterial, fungal, viral or protozoal infections or tumors
11/11/2004	US20040224902 Process for obtaining lignans
11/11/2004	US20040224896 STQ peptides
11/11/2004	US20040224877 drug delivery method of deglycosylated Vitamin D binding protein (DBP-maf) for angiogenesis inhibition; anticarcinogenic, antitumor agents
11/11/2004	US20040224864 sterilization of embolic compositions comprising hydroxyl-containing rheological modifier(s) using irradiation techniques provides sterilized compositions exhibiting minimal changes in its thioxotropic behavior; prolonged shelf life with limited changes in viscosity
11/11/2004	US20040224424 Nucleotide sequences comprising allelic variant of cytochrome p450 for use in diagnosis and treatment of cell proliferative, nervous system and cardiovascular disorders; pharmacodynamic profiles and drug screening
11/11/2004	US20040224393 Modified human granulocyte-colony stimulating factor and process for producing same
11/11/2004	US20040224378 Methods for using ADAMTS-12, an integrin and metalloprotease with thrombspondin motifs
11/11/2004	US20040224363 Immunoglobulin for use in diagnosis and prognosis of metastatic breast cancer and degenerative neural conditions; drug screening; immunotherapy and diagnostics; anticarcinogenic agents
11/11/2004	US20040224356 Novel human enzymes of the metalloprotease family
11/11/2004	US20040224355 Using guanylate cyclase gene expression for imaging and treating primary and/or metastatic stomach or esophageal cancer; tissue targeted therapy; genetic vaccines; immunotherapy
11/11/2004	US20040224347 Methods for identification, diagnosis, and treatment of breast cancer
11/11/2004	US20040224323 PAK5 screening methods
11/11/2004	US20040224314 G-protein coupled receptors
11/11/2004	US20040224023 Compositions and methods for treating or preventing diseases of body passageways
11/11/2004	US20040223969 modulating tumor growth by contacting a tumor cell with an agonist or antagonist of IL-23, particularly a binding mixture of IL-23R or nucleotide coding it comprising: an antigen-binding site of an antibody; an extracellular region of IL-23R; a small molecule; and an anti-sense nucleic acid or siRNA
11/11/2004	US20040223968 inhibiting a condition characterized by monocytic infiltrates such as atherosclerosis by administering an MCP-1 receptor antagonist that binds to an MCP-1 receptor polypeptide, especially a humanized or monoclonal antibody.
11/11/2004	US20040223953 Combined adeno-associated virus and adenovirus cocktail gene delivery system for high efficiency gene expression without eliciting immune response in immuno-competent subjects
11/11/2004	US20040223949 administering a tumor antigen, fragment thereof or nucleic acid encoding it to produce an immune response and subsequently administering a high dose of a cytokine; provides an enhanced T cell response
11/11/2004	US20040223915 Cytostatic cerium compounds
11/11/2004	US20040223911 Stabilized therapeutic and imaging agents
11/11/2004	DE19718245C5 Synthetische Triglyceride auf Basis konjugierter Linolsäure, Verfahren zu deren Herstellung und deren Verwendung Synthetic triglycerides based on conjugated linoleic acid, processes for their preparation and their use
11/11/2004	DE10318610A1 7-Azaindole und deren Verwendung als Therapeutika 7-azaindoles and their use as therapeutic agents
11/11/2004	CA2826735A1 Methods for treating cancer using an immunotoxin
11/11/2004	CA2536964A1 C-fms kinase inhibitors
11/11/2004	CA2523868A1 Combinations comprising a protein tyrosine kinase receptor antagonist and a chemotherapeutic or naturally occurring, semi-synthetic of synthetic therapeutic agent for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells, or angiogenesis
11/11/2004	CA2523830A1 Methods and compositions using gonadotropin hormone releasing hormone
11/11/2004	CA2523600A1 Methods utilising g-protein coupled receptor 54
11/11/2004	CA2523577A1 Methods for treating interleukin-6 related diseases
11/11/2004	CA2523517A1 Bcl2l12 polypeptide activators and inhibitors
11/11/2004	CA2523508A1 Galectin 9-inducing factors

1 ... 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 1372 1373 1374 1375 1376 ... 2211